When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review

JACC This Week
15/01/2024 25 min
When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review

Listen "When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review"

Descargar episodio Ver en sitio original

Episode Synopsis

Commentary by Dr. Valentin Fuster

More episodes of the podcast JACC This Week

Computable Quality, Community Screening, and TAVR Debate | JACC This Week 29/09/2025
AI, Polygenic Risk Scores, and Antithrombotic Therapy | JACC This Week 15/09/2025
Reframing Cardiovascular Care | JACC This Week 08/09/2025
Heart Failure Insights, AI Standards, and Genetic Clues | JACC This Week 03/09/2025
Cognitive Risk in CHD and Cardiology Practice Meets Lifestyle Realities | JACC This Week 25/08/2025
Pacing Strategies, Air Quality, and the Path to Equity | JACC This Week 18/08/2025
Device Safety, DAPT Strategy & Structural Innovation | JACC This Week 11/08/2025
Amyloidosis in Focus: Biomarkers, Structural Insights & Therapeutic Strategy | JACC This Week 04/08/2025
Out-of-Hospital Cardiac Arrest in Septuagenarians, Octogenarians, and Nonagenarians in Japan: Trends and Patterns in Outcomes | JACC Baran 29/07/2025
Zeroing In on Prevention: ARIC and the Future of Cardiovascular Risk | JACC Baran 29/07/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA